Skip to content

Chemed CHE Return on equity

Return on equity at other companies

Louisiana-Pacific Corporation logo
Louisiana-Pacific CorporationLPX
5.3%-19.1pp
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-52.8%-12.7pp
SentinelOne logo
SentinelOneS
-21.4%-3.7pp
Alaska Air Group logo
Alaska Air GroupALK
1.9%-7.0pp
UCT
Ultra Clean HoldingsUCTT
-25.9%-29.2pp
Paylocity logo
PaylocityPCTY
21.6%+1.9pp

Other financials

Income statement

See full
Revenue$657.5M+1.6%
Gross profit$215.8M-0.3%
Operating income$84.6M-10.7%
Net income$66.3M-7.6%
EPS (diluted)$4.84-0.4%

Balance sheet

See full
Cash & equivalents$16.9M-90.3%
Total debt$236.9M+63.3%
Total equity$848.0M-28.2%
Total assets$1.5B-11.0%

Cash flow

See full
Operating cash flow$88.2M+169%
CapEx$17.1M+28.9%
Free cash flow$71.1M+265%

Valuation

See full
Market cap$5.79B-42.3%
Enterprise value$6.01B-39.6%
P/E22.3×-10.2×
P/S2.3×-1.8×

Profitability

See full
Gross margin32.4%-2.4pp
Operating margin12.9%-2.7pp
Net margin10.2%-2.2pp
FCF margin14.8%+2.2pp

Returns & leverage

See full
Debt / equity0.3×+0.2×
Current ratio0.9×-0.9×

Where this comes from

Calculated from Chemed’s reported figures.

Based on trailing twelve months.

The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemed's return on equity?
Chemed (CHE) reported return on equity of 25.6% in Q1 2026.
How has Chemed's return on equity changed year-over-year?
Chemed's return on equity decreased by 1.9% year-over-year, from 26.1% to 25.6%.
What is the long-term trend for Chemed's return on equity?
Over 5 years (2020 to 2025), Chemed's return on equity has grown at a -8.4% compound annual growth rate (CAGR), from 39.3% to 25.3%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.